Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24062193)

1.
2.

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.

De Hert M, Yu W, Detraux J, Sweers K, van Winkel R, Correll CU.

CNS Drugs. 2012 Sep 1;26(9):733-59. doi: 10.2165/11634500-000000000-00000. Review.

PMID:
22900950
3.

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2009 Dec;63(12):1762-84. doi: 10.1111/j.1742-1241.2009.02228.x. Epub 2009 Oct 14. Review.

PMID:
19840150
4.

Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.

Citrome L.

Postgrad Med. 2011 Mar;123(2):153-62. doi: 10.3810/pgm.2011.03.2273. Review.

PMID:
21474903
5.

Iloperidone, asenapine and lurasidone: a primer on their current status.

Tarazi FI, Stahl SM.

Expert Opin Pharmacother. 2012 Sep;13(13):1911-22. doi: 10.1517/14656566.2012.712114. Epub 2012 Jul 31. Review.

PMID:
22849428
6.

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2011 Feb;65(2):189-210. doi: 10.1111/j.1742-1241.2010.02587.x. Epub 2010 Dec 3. Review.

PMID:
21129135
7.

Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.

Bobo WV.

Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91. doi: 10.1586/ecp.12.70. Review.

PMID:
23272794
8.

Lurasidone in schizophrenia: new information about dosage and place in therapy.

Citrome L.

Adv Ther. 2012 Oct;29(10):815-25. doi: 10.1007/s12325-012-0052-6. Epub 2012 Sep 20. Review.

PMID:
23001538
9.
10.

Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2009 Aug;63(8):1237-48. doi: 10.1111/j.1742-1241.2009.02142.x. Review.

PMID:
19624791
11.
12.

Lurasidone for schizophrenia: what's different?

Kantrowitz JT, Citrome L.

Expert Rev Neurother. 2012 Mar;12(3):265-73. doi: 10.1586/ern.12.7. Review.

PMID:
22364325
13.

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU.

Clin Neuropharmacol. 2013 Nov-Dec;36(6):223-38. doi: 10.1097/WNF.0b013e3182aa38c4. Review.

PMID:
24201235
14.

Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapy.

Citrome L.

Adv Ther. 2013 Feb;30(2):114-26. doi: 10.1007/s12325-013-0006-7. Epub 2013 Jan 28. Review.

PMID:
23361833
15.

Asenapine review, part II: clinical efficacy, safety and tolerability.

Citrome L.

Expert Opin Drug Saf. 2014 Jun;13(6):803-30. doi: 10.1517/14740338.2014.908183. Epub 2014 May 3. Review.

PMID:
24793161
16.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM.

Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27. Review. Erratum in: Lancet. 2013 Sep 14;382(9896):940.

PMID:
23810019
17.

Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability.

Bishara D, Taylor D.

Drugs. 2008;68(16):2269-92. doi: 10.2165/0003495-200868160-00002. Review.

PMID:
18973393
18.

Cariprazine in bipolar disorder: clinical efficacy, tolerability, and place in therapy.

Citrome L.

Adv Ther. 2013 Feb;30(2):102-13. doi: 10.1007/s12325-013-0004-9. Epub 2013 Jan 28. Review.

PMID:
23361832
19.

Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.

Citrome L.

Clin Schizophr Relat Psychoses. 2011 Jan;4(4):251-7. doi: 10.3371/CSRP.4.4.5. Review.

PMID:
21177242
20.

Lurasidone: a new treatment option for schizophrenia.

Owen RT.

Drugs Today (Barc). 2011 Nov;47(11):807-16. doi: 10.1358/dot.2011.47.11.1708832. Review.

PMID:
22146224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk